NM_133459.4:c.*4749C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_133459.4(CCBE1):​c.*4749C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.831 in 152,184 control chromosomes in the GnomAD database, including 52,715 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.83 ( 52714 hom., cov: 32)
Exomes 𝑓: 0.75 ( 1 hom. )

Consequence

CCBE1
NM_133459.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.31

Publications

2 publications found
Variant links:
Genes affected
CCBE1 (HGNC:29426): (collagen and calcium binding EGF domains 1) This gene is thought to function in extracellular matrix remodeling and migration. It is predominantly expressed in the ovary, but down regulated in ovarian cancer cell lines and primary carcinomas, suggesting its role as a tumour suppressor. Mutations in this gene have been associated with Hennekam lymphangiectasia-lymphedema syndrome, a generalized lymphatic dysplasia in humans. [provided by RefSeq, Mar 2010]
CCBE1 Gene-Disease associations (from GenCC):
  • Hennekam lymphangiectasia-lymphedema syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • Hennekam syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 18-59431159-G-A is Benign according to our data. Variant chr18-59431159-G-A is described in ClinVar as Benign. ClinVar VariationId is 327591.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.887 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_133459.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCBE1
NM_133459.4
MANE Select
c.*4749C>T
3_prime_UTR
Exon 11 of 11NP_597716.1Q6UXH8-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCBE1
ENST00000439986.9
TSL:1 MANE Select
c.*4749C>T
3_prime_UTR
Exon 11 of 11ENSP00000404464.2Q6UXH8-1
CCBE1
ENST00000649564.1
c.*4749C>T
3_prime_UTR
Exon 12 of 12ENSP00000497183.1Q6UXH8-1
CCBE1
ENST00000650467.2
c.*4749C>T
3_prime_UTR
Exon 9 of 9ENSP00000496897.2A0A3B3IRL6

Frequencies

GnomAD3 genomes
AF:
0.831
AC:
126403
AN:
152062
Hom.:
52673
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.890
Gnomad AMI
AF:
0.818
Gnomad AMR
AF:
0.805
Gnomad ASJ
AF:
0.815
Gnomad EAS
AF:
0.883
Gnomad SAS
AF:
0.910
Gnomad FIN
AF:
0.761
Gnomad MID
AF:
0.851
Gnomad NFE
AF:
0.804
Gnomad OTH
AF:
0.812
GnomAD4 exome
AF:
0.750
AC:
3
AN:
4
Hom.:
1
Cov.:
0
AF XY:
1.00
AC XY:
2
AN XY:
2
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.750
AC:
3
AN:
4
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.831
AC:
126502
AN:
152180
Hom.:
52714
Cov.:
32
AF XY:
0.829
AC XY:
61665
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.890
AC:
36968
AN:
41530
American (AMR)
AF:
0.805
AC:
12301
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.815
AC:
2828
AN:
3472
East Asian (EAS)
AF:
0.883
AC:
4563
AN:
5170
South Asian (SAS)
AF:
0.909
AC:
4389
AN:
4826
European-Finnish (FIN)
AF:
0.761
AC:
8055
AN:
10584
Middle Eastern (MID)
AF:
0.850
AC:
250
AN:
294
European-Non Finnish (NFE)
AF:
0.804
AC:
54685
AN:
67992
Other (OTH)
AF:
0.814
AC:
1717
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1112
2225
3337
4450
5562
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
890
1780
2670
3560
4450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.814
Hom.:
94906
Bravo
AF:
0.833
Asia WGS
AF:
0.893
AC:
3106
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hennekam lymphangiectasia-lymphedema syndrome 1 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.14
DANN
Benign
0.49
PhyloP100
-1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1048006; hg19: chr18-57098391; API